Percutaneous radiofrequency thermal ablation in the management of lung tumors: presentation of clinical experience on a series of 35 patients
    PDF
    Cite
    Share
    Request
    Interventional Radiology - Original Article
    P: 290-296
    December 2009

    Percutaneous radiofrequency thermal ablation in the management of lung tumors: presentation of clinical experience on a series of 35 patients

    Diagn Interv Radiol 2009;15(4):290-296
    1. Departments of Radiology, Sotiria Hospital Athens, Greece
    2. Department of Radiology, Red Cross Hospital of Athens, Athens, Greece
    3. Departments of Radiology, Alexandra General Hospital Athens, Greece
    4. Department of Nuclear Medicine, University Hospital of Ioannina, Athens, Greece
    5. Departments of Radiology, Alexandra General Hospital Athens, Greece
    6. Department of Pathology, Ippokrateio Hospital, Athens, Greece
    7. Departments of Radiology, Red Cross Hospital Athens, Greece
    No information available.
    No information available
    Received Date: 31.03.2008
    Accepted Date: 23.10.2008
    PDF
    Cite
    Share
    Request

    ABSTRACT

    PURPOSE

    To present our results in a series of 35 patients with malignant pulmonary lesions, who underwent radiofrequency thermal ablation (RFA) during a period of 18 months.

    MATERIALS AND METHODS

    In our institution, 55 RFA sessions under computed tomography (CT) guidance were performed on 48 pulmonary malignant lesions (23 inoperable primary and 25 metastatic) in 35 patients.

    RESULTS

    Total necrosis was noted in 19 primary (82.6%) and in 19 metastatic lesions (76%). In four primary (17.4%) and in six metastatic lesions (14%), partial necrosis was achieved, and a second RFA session was performed. The 6-month spiral CT follow-up demonstrated recurrence in seven lesions (14.5%) (four primary and three metastatic), which were treated with an additional RFA session. Two of the patients who underwent the procedure died of disseminated disease after one year, accounting for a 1-year survival rate of 94.2%. Mean survival was 14.48 ± 3.3 months.

    CONCLUSION

    RFA is an effective method for treating unresectable lung carcinoma and lung metastases.

    Keywords: radiofrequency catheter ablation, lung neoplasms, neoplasm metastasis

    References

    2024 ©️ Galenos Publishing House